Netherlands Respiratory Devices Market Size (2024 - 2029)

Netherlands Respiratory Devices Market Analysis

The Dutch respiratory devices market is expected to grow with a CAGR of 9.6% during the forecast period.

During the COVID-19 pandemic, the demand for major respiratory devices such as ventilators, nebulizers, CPAP, BiPAP, and oxygen concentrators increased due to the high number of COVID-19-infected patients in the country. With the increased severity of COVID-19 in the country, several companies increased their ventilator production to combat the pandemic. For instance, in April 2020, Medtronic ramped up the production of ventilators by more than 40%, increasing the capacity to make and supply the devices to hospitals globally. Also, in April 2020, the Philips Foundation partnered with Refugee Company and its feedstock supplier to provide a loan for two mask-making machines to alleviate the shortage of medical face masks in the Netherlands. This indicates the urgent need for respiratory devices like ventilators, oxygen concentrators, and nebulizers, especially for COVID-19 patients in the country. Moreover, with the released COVID-19 restrictions and resumed treatment and elective surgery procedures, the demand for respiratory devices is expected to increase over the forecast period.

Certain factors attributing to the market growth are the increasing prevalence of respiratory disorders and growing applications in home care settings.

In addition, the rising geriatric population, who are more prone to develop respiratory disorders due to their weak immunity, is also contributing to the market growth. For instance, according to the 2022 statistics published by the UNPF in the Netherlands, a large proportion of the living population was aged between 15 and 64, accounting for 64% in 2022. In addition, as per the same source, 21% of the population was aged 65 years and above in 2022.

The increasing burden of respiratory diseases such as asthma, lung cancer, chronic obstructive pulmonary disease (COPD), sleep apnea, and tuberculosis among the population is also expected to increase the market growth over the forecast period. For instance, as per GLOBOCAN 2020 factsheet, about 13,500 new lung cancer cases were reported in the Netherlands in 2020. Also, the increasing number of smokers in the country raises the risk of developing lung cancer and other respiratory problems, which, in turn, is expected to increase the demand for respiratory devices. For instance, as per the statistics published by Netherlands Expertise Center for Tobacco Control in June 2022, about 20.6% of adults aged 18 years and older in the Netherlands smoked in 2021. Thus, the rising prevalence of respiratory issues among the population is expected to increase the demand for ventilators and other respiratory devices, thereby propelling the market's growth.

Additionally, as per an article published in European Respiratory Journal in July 2021, it was found that the prevalence of chronic obstructive pulmonary disease (COPD) is anticipated to increase in Europe (including the Netherlands) due to rising risk factors like smoking and air pollution. Similarly, from an article published in PLOS One in November 2022, it was found that the frequency of COPD in patients with COVID-19 was the highest in the Netherlands at 17% in 2021. Thus, the expected increase in the number of people suffering from COPD in the country and the rising prevalence is expected to increase the demand for inhalers and nebulizers to deliver various COPD medications to patients, which, in turn, is anticipated to propel the demand for respiratory devices over the forecast period.

Furthermore, rising government initiatives are also contributing to the market's growth. For instance, in May 2021, the Netherlands shipped 449 ventilators, 100 oxygen concentrators, and other medical supplies to India to fight against the COVID-19 pandemic. This is anticipated to increase the company's focus on accelerating the production of ventilators and oxygen concentrators, thereby propelling the market's growth.

Therefore, owing to the aforementioned factors, the market studied is expected to grow over the forecast period. However, the high cost of devices such as ventilators and respiratory humidifier are likely to impede market growth during the forecast period.

Netherlands Respiratory Devices Industry Segmentation

As per the scope of the report, respiratory devices include respiratory diagnostic devices, therapeutic devices, and breathing devices for administering long-term artificial respiration. It may also include a breathing apparatus used for resuscitation by forcing oxygen into the lungs of a person who has undergone asphyxia. 

The Dutch respiratory devices market is segmented by type (diagnostic and monitoring devices (spirometers, sleep test devices, peak flow meters, and other diagnostic and monitoring devices), therapeutic devices (ventilators, inhalers, CPAP devices, and other therapeutic devices), and disposables (masks, breathing circuits, and other disposables). The report offers values in USD million for all the above-mentioned segments.